A recent lightning rod for abortion opponents, the drug mifepristone—the first of two in the standard medication abortion regimen—surfaced several times during Robert F. Kennedy, Jr.’s first Senate confirmation hearing as President Trump’s pick for Health and Human Services secretary.

Robert F. Kennedy Jr had an absolute trainwreck of a confirmation hearing. Kennedy, who had been a vocal vaccine skeptic and preached numerous disproven conspiracy theories, was lambasted for his anti-science stance and his refusal to stop suing the very companies he now wants to regulate.

Judge Matthew Kacsmaryk, a Trump appointee, allowed three states to go forward with a lawsuit that seeks to change how mifepristone is used.

A higher dose of an emergency-contraception drug may open a back door for Americans seeking abortions in restrictive states.

Meanwhile, in an executive order, Trump created his long-discussed “Department of Government Efficiency,” to be led by Elon Musk, the world’s richest man. On paper, the department is tasked with modernizing federal technology and software; however, Trump and Musk have spent months boasting about how it will gut the federal government.

A new study shows a possible new abortion drug to replace mifepristone. But will these results increase abortion access—or restrict women's reproductive health options down the line?

The anti-abortion movement has launched a pressure campaign urging President Donald Trump’s administration to take steps toward a nationwide ban on medication abortion, the method used in nearly two-thirds of all abortions nationwide.

Last Friday, my colleague Julianne McShane and I broke the news of a pair of letters sent by 30 prominent anti-abortion movement leaders to the heads of the Departments of Health and Human Services and Justice, asking them to use the powers of their agencies to attack abortion pills.

The new Trump administration could put a stop to pending litigation on the abortion pill mifepristone and other federal abortion policies through changes at the Department of Health and Human Services, according to a top anti-abortion lawyer involved in several pending cases.

After the Supreme Court overturned Roe in 2022, anti-abortion advocates launched a barrage of litigation, including a federal suit in Texas aimed at mifepristone, one drug in a two-drug regimen used in medication abortions.

Here are some of the actions Trump’s nominees could take on abortion, if confirmed, from HHS to the Justice Department.

Robert F. Kennedy Jr. made several disturbing comments during his first Senate confirmation hearing Wednesday suggesting that, as Donald Trump’s secretary of health and human services, he’s hoping to limit access to the abortion pill mifepristone.